Semaglutide
A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®
Novo Nordisk · Phase 3 · Status n/r · Enrollment 370
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Semaglutide injection | Obesity or overweight | n/r | 4 | n/r | n/r |
| Wegovy® | Obesity or overweight | n/r | 4 | n/r | n/r |